Aging is usually associated with declining cognitive function and reduced sleep duration and fragmentation are also common in older adults, and lead to impairments in memory and executive function. Poor sleep has been identified as a risk factor for various health conditions. In the context of Alzheimer’s, a possible correlation exists. This review explores the complex relationship between sleep and Alzheimer’s disease, emphasizing the potential effect of sleep disturbances on Alzheimer’s and the potential mechanisms linking the two. A comprehensive literature review was conducted using databases such as PubMed, NCBI Bookshelf, Elsevier, Google Scholar, ResearchGate, and Springer. The timeframe of the literature was set within the range of 2010 to 2025. Papers published in English, including clinical, review papers, and original research articles, were reviewed to write this paper. An AI tool, Anara, was also used as an assistant in identifying relevant publications, patterns, and areas lacking research. Evidence invariably supports a bidirectional relationship between sleep disturbance and Alzheimer’s pathology, particularly amyloid-β and tau protein. Disrupted sleep may accelerate disease pathology, while its progression impairs sleep quality. This feedback loop amplifies cognitive decline over time. However, understanding of the mechanisms underlying Aβ aggregation and Tau affecting sleep remains obscure. Few studies evaluate the impact of therapeutic interventions, both pharmacological and non-pharmacological treatment of sleep on Alzheimer’s disease progression.Sleep disturbances are a modifiable risk factor for Alzheimer’s disease. Understanding the sleep-targeted interventions may offer novel strategies for delaying cognitive decline in Alzheimer’s patients.